Recently, glucagon-like peptide-1 (GLP-1) analogs have shown promise in targeting pathophysiological pathways implicated in BED
Therefore, using a large, real-world population with type 2 diabetes, we constructed a model to assess the cost-effectiveness of widespread use of SGLT2is and GLP-1 RAs in people with type 2 diabetes, considering only major cardiovascular and kidney outcomes
It reflects the underlying biology of obesity and metabolic disease
Moreover, shopping from HealthKart provides fast delivery, exclusive offers, and dependable customer support, and your shopping experience becomes seamless
VCO appears to have antioxidant and anti-inflammatory characteristics that protect against the tissue toxicity of anti-neoplastic and anti-retroviral treatment (Famurewa et al